SLEEP MEDICATION USE IN CANADIAN SENIORS

Main Article Content

C Ineke Neutel
Scott B Patten

Keywords

Sleep medication, comorbidity, elderly, quality of sleep

Abstract

Background


Difficulty sleeping is a common complaint by older people which leads to medication use to help attain sleep.


 


Objectives


This study provides a population-based description of medication, specifically taken to help with sleep, by Canadians over the age of 60. The proportion of this sleep medication that is prescribed, and the determinants of prescribed versus over-the-counter (OTC) sleep medication use will also be presented.


 


Methods


The Canadian Community Health Survey, 2002, provided the study population of 9,393 respondents over the age of 60.


 


Results


Almost 16% of Canadians over 60 reported taking sleep medication over the past year, of which 85% was prescribed by physicians. Sleep medication is higher for women, increases with age, poor health, chronic illness and poor quality sleep, and was especially high for people with a recent major depressive episode. Prescribed sleep medication increased with age, low income, low education, poor health, chronic illness and residence in the province of Quebec. Adjusting for health status or insurance covering medication costs made little difference.


 


Conclusions


This study provides important new information on the use of sleep medication by older Canadians. Overall sleep medication use and proportion of sleep medication prescribed are separate parameters with potentially different distributions, e.g., Quebec showed the same amount of sleep medication use as elsewhere, but a much higher proportion of it was prescribed

Abstract 169 | PDF Downloads 66

References

1. State-of-the-Science Panel. National Institutes of Health State-of the-Science Conference statement on manifestations and management of chronic insomnia in adults, June 13–15, 2005. http://consensus.nih.gov/2005/2005InsomniaSO S026html.htm
2. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ 2000;162:216- 20.
3. Pagel JF, Parnes BL. Medications for the Treatment of Sleep Disorders: An Overview. Prim Care Companion J Clin Psychiatry 2001;3:118-125.
4. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep 2000;23 Suppl 1:S23-30.
5. Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness J. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. Euro J Clin Pharmacol 2009;65:295-301.
6. Wagner J, Wagner ML. Non-benzodiazepines for the treatment of insomnia. Sleep Med Rev. 2000; 4:551-581.
7. Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003;26: 261-82.
8. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225- 33.
9. Busto UE, Sproule BA, Knight K, Herrmann N. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol 2001;8: 213-21.
10. Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 2005;56:332- 43.
11. Sproule BA, Busto UE, Buckle C, Herrmann N, Bowles S. The use of non-prescription sleep products in the elderly. Int J Geriatr Psychiatry 1999;14:851-7.
12. Roehrs T, Hollebeek E, Drake C, Roth T. Substance use for insomnia in Metropolitan Detroit. J Psychosom Res 2002;53:571-6.
13. Bartlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, du Berger R. Longitudinal patterns of new Benzodiazepine use in the elderly. Pharmacoepidemiol Drug Saf 2004;13:669-82.
14. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13:83-121.
15. Neutel CI. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry 2005;17:189-97.
16. Barbui C, Gregis M, Zappa M. A cross-sectional audit of benzodiazepine use among general practice patients. Acta Psychiatr Scand 1998;7:153-156.
17. Balkrishnan R, Rasu RS, Rajagopalan R. Physician and patient determinants of pharmacologic treatment of sleep difficulties in outpatient settings in the United States. Sleep 2005;28:715-9.
18. Ohayon MM, Caulet M. Insomnia and psychotropic drug consumption. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:421-31.
19. Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepines use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Pharmacol 2001;57:419-425.
20. Neutel CI, Walop W. Drug utilization by men and women: Why the difference? Drug Information Journal 2005;39:299-310.
21. DesMeules M, Stewart D, editors. Women’s health surveillance report. A multi-dimensional look at the health of Canadian women. Ottawa, Canada: Health Canada, 2003.
22. Mah L, Upshur RE. Long term benzodiazepine use for insomnia in patients over the age of 60: discordance of patient and physician perceptions. BMC Fam Pract 2002; http://www.biomedcentral.com/1471-2296/3/9:
23. Krueger PM, Friedman EM. Sleep duration in the United States: A cross-sectional populationbased study. American Journal of Epidemiology 2009;169:1052-1063.
24. Roehrs T, Burduvali E, Bonahoom A, Drake C, Roth T. Ethanol and sleep loss: a "dose" comparison of impairing effects. Sleep 2003;26:981-5.
25. Roehrs T, Papineau K, Rosenthal L, Roth T. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacology 1999;20:279-86.
26. Roth T, Roehrs T. Insomnia: epidemiology, characteristics and consequences. Clin Cornerstone 2003;5:5-15.
27. Mendelson WB, Roth T, Cassella J, et al. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev 2004;8:7- 17.
28. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994;150:1801-1809.
29. Ohayon MM, Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 1996;41:457-64.
30. Ancoli-Israel S, Poceta JS, Stepnowsky C, Martin J, Gehrman P. Identification and treatment of sleep problems in the elderly. Sleep Med Rev 1997;1:3-17.
31. Shochat T, Loredo J, Ancoli-Israel S. Sleep Disorders in the Elderly. Curr Treat Options Neurol 2001;3:19-36.

Most read articles by the same author(s)